1130 Group specializes in the research and development of ancillary inhalation devices, particularly tailored for 420 and 710 formulations. Drawing upon extensive experience in US medical device development and engineering, our design initiative originated in New York, resulting in the US Patent-protected "flagship" technology. This pioneering technology provides a novel approach for end-users to consume extracts, establishing a robust foundation for the advancement of inhalation methods. Our commitment to innovation is driven by the recognition that current industry standards are inadequately positioned to meet future FDA compliance and regulatory requirements.
Established in 2021
Founded in 2021, following its inception in 2015, the Clarity Pen® system embarked on the journey of initial prototyping and collaboration with key stakeholders within the industry. Promptly recognizing numerous shortcomings inherent in existing inhalation devices, our pioneers discerned the necessity for an enhanced process or technique capable of ensuring future regulatory compliance within the evolving landscape of the industry. This keen understanding of the deficiencies impacting the efficacy of inhalation therapeutics spurred an investment in a CE and RoHS-certified electronics company in Shenzhen, China, initiating efforts to secure global patent protection, ultimately granted by the US in August 2021.
Our Goal
From the outset, it became evident that "air-activated" cartridges containing filaments within pre-filled hardware accelerated the degradation of extracts, often before end-users could reap their benefits. This glaring inadequacy prompted an examination of the transportation process and its impact on the efficacy of pre-filled extracts. As these extracts traversed ground and air transportation and awaited acquisition on shelves, they were susceptible to oxidation and external contaminants, compromising their quality. The Clarity Pen® system seeks to address these challenges by ensuring consistency and transparency, providing a robust solution to the community.